ARYZTA AG stock analysis
ARYZTA AG (ARZTF) Stock Price & Analysis
ARZTF Stock Chart & Stats
- Day’s Range
- $50.25 - $52.60
- 52-Week Range
- $41.88 - $80.04
- Previous Close
- $50.07
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $1.27B
- Enterprise Value
- $2.12B
- Total Cash (Recent Filing)
- $74.40M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- 12.8
- Beta
- 0.15
- Next Earnings
- Mar 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jan 30, 2017
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Profitability Turnaround
The return to positive operating and net margins, combined with stronger gross margin, indicates that ARYZTA’s earnings recovery is becoming more established. Improved profitability can support reinvestment, debt reduction, and resilience across the next several quarters despite uneven demand.
Cash Generation
Positive free cash flow that is translating reasonably well from earnings strengthens the company’s ability to fund operations internally. This supports ongoing deleveraging and strategic investment while reducing reliance on external financing as the business manages its recovery.
Cost Savings And Innovation
The savings program provides a multi-year path to structural efficiency gains, while the high innovation rate supports premiumization and contributed to gross-margin improvement. Successful execution could offset demand volatility and make future margin recovery more durable.
Bears Say
Weak Organic Growth And Germany
Negative organic growth and pronounced German weakness show that ARYZTA’s near-term expansion remains constrained in an important European market. Continued regional softness could limit operating leverage and make the company’s full-year improvement targets more execution-dependent.
Debt-heavy Capital Structure
Although leverage has improved, debt still exceeds equity and cash-flow coverage remains moderate. This limits financial flexibility if earnings soften, and it can constrain the pace at which ARYZTA funds growth, absorbs disruption, or returns capital.
Margin Pressure
The margin decline shows that cost inflation, negative operational leverage, and restructuring expenses are still absorbing efficiency gains. Recovery depends on successful savings execution and improved demand, leaving profitability vulnerable if European pressure persists.
ARYZTA AG News
ARZTF FAQ
What was ARYZTA AG’s price range in the past 12 months?
What is ARYZTA AG’s market cap?
When is ARYZTA AG’s upcoming earnings report date?
How were ARYZTA AG’s earnings last quarter?
Is ARYZTA AG overvalued?
Does ARYZTA AG pay dividends?
What is ARYZTA AG’s EPS estimate?
How many shares outstanding does ARYZTA AG have?
What happened to ARYZTA AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ARYZTA AG?
What is the TipRanks Smart Score and how is it calculated?
Company Description
ARYZTA AG
Established in 1897 and headquartered in Schlieren, Switzerland, ARYZTA AG delivers frozen, business-to-business (B2B) bakery products across Europe, Asia, Australia, New Zealand, and South America. Its extensive product range includes various bread rolls, artisanal loaves, a selection of sweet baked and morning goods, and savory items. Beyond its primary baking operations, the company also offers asset management services and distributes food products. ARYZTA serves a broad customer base, encompassing large retail chains, convenience stores, independent retailers, quick-service restaurants, and other foodservice clients. The company maintains a significant operational footprint with 32 bakeries located in 28 countries.
- Sector
- General
- Industry
- Packaged Foods
- CEO
- Urs Jordi
- Employees
- 7,774
- Website
- www.aryzta.com
- Address
- Ifangstrasse 9, Schlieren, ZH, 8952, CH
ARYZTA AG (ARZTF) Earnings & Revenues
ARZTF Earnings Call
Earnings Call SentimentNeutral
The call paints a mixed picture: near-term top-line pressure and notable regional weakness in Germany drove organic decline and margin compression, but material positives include clear progress on Project Excellence, confirmed cost savings (EUR 8–10M to date), stronger capital structure (net debt down ~EUR 100M, leverage 2.7x), stable free cash flow, a high innovation rate (~19%), and strategic actions (hybrid repayment, French bolt-on acquisition, Perth ramp). Management reiterated full-year profit improvement targets while guiding to the lower end of organic growth, and they are assessing options for Germany with further clarity expected in H2. Overall, upside depends on execution of cost programs and stabilization in European demand.
View all ARZTF earnings summariesARZTF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 5 |
| Technical Analysis | 3 | 5 | 1 |
| Moving Averages | 8 | 0 | 4 |








